Advertisement

Inflammation

, Volume 31, Issue 4, pp 247–253 | Cite as

Dynamic Changes of Matrix Metalloproteinase-9 in Patients with Klebsiella pneumoniae Meningitis

  • Hung-Chin Tsai
  • Sheng-Fu Liu
  • Kuan-Sheng Wu
  • Yung-Ching Liu
  • Min-Hon Shi
  • Eng-Rin Chen
  • Chuan-Min Yen
  • Susan Shin-Jung Lee
  • Yen-Lin Huang
  • Yao-Shen Chen
Article

Abstract

To quantitate cerebrospinal fluid (CSF) concentrations of matrix metalloproteinase 9 (MMP-9) in adult patients with Klebsiella pneumoniae meningitis and to correlate levels of MMP-9 with parameters of intrathecal inflammation and analyze the kinetic changes of MMP-9. In a prospective cohort study, levels of MMP-9 and tissue inhibitor of matrix metalloproteinase (TIMP-1) concentrations were measured in the CSF of six adult patients with meningitis and 11 controls. MMP-9 and TIMP-1 were detected in all of the six patients at presentation and follow up lumbar puncture. CSF levels of MMP-9 (6.71 ± 7.29 ng/ml) and TIMP-1(454.3 ± 242.9 ng/ml) were higher in patients than in the control group (0.07 ± 0.11 ng/ml and 27.14 ± 39.34 ng/ml, respectively). Levels of MMP-9 correlated with CSF concentrations of protein, cell count and lactate. Repeated lumbar punctures showed that levels of MMP-9 decrease during clinical recovery, although the levels of MMP-9 in the CSF are variable because of the small number of cases. The relative change in gelatin zymography is comparable to the changes of MMP-9 levels found in ELISA. MMP-9 levels in CSF may be a useful tool in follow-up in patients with K. pneumoniae meningitis.

KEY WORDS

gelatin zymography Klebsiella pneumoniae matrix metalloproteinase 9 meningitis 

Notes

Acknowledgments

This work is supported by the Summer Medical Student Research Program 2007, from the Medical Foundation in Memory of Dr. Deh-Lin Cheng and also supported by grant VGHKS96-027 from Kaohsiung Veterans General Hospital, and grant NSC-96-2320-B-075B-002 from the National Science Council, Republic of China.

References

  1. 1.
    Lu, C. H., W. N. Chang, and H. W. Chang. 2000. Adult bacterial meningitis in Southern Taiwan: epidemiologic trend and prognostic factors. J. Neurol. Sci. 182:36–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Tang, L. M., S. T. Chen, W. C. Hsu, and C. M. Chen. 1997. Klebsiella meningitis in Taiwan: an overview. Epidemiol. Infect. 119:135–142.PubMedCrossRefGoogle Scholar
  3. 3.
    Lee, P. Y., W. N. Chang, C. H. Lu, M. W. Lin, B. C. Cheng, C. C. Chien, C. J. Chang, and H. W. Chang. 2003. Clinical features and in vitro antimicrobial susceptibilities of community-acquired Klebsiella pneumoniae meningitis in Taiwan. J. Antimicrob. Chemother. 51:957–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Lu, C. H., W. N. Chang, Y. C. Chuang, and H. W. Chang. 1998. The prognostic factors of adult gram-negative bacillary meningitis. J. Hosp. Infect. 40:27–34.PubMedCrossRefGoogle Scholar
  5. 5.
    Tang, L. M., and S. T. Chen. 1994. Klebsiella pneumoniae meningitis: prognostic factors. Scand J Infect Dis. 26:95–102.PubMedCrossRefGoogle Scholar
  6. 6.
    Pfister, H. W., and W. M. Scheld. 1997. Brain injury in bacterial meningitis: therapeutic implications. Curr. Opin. Neurol. 10:254–254.PubMedCrossRefGoogle Scholar
  7. 7.
    Täuber, M. G., Y. S. Kim, and S. L. Leib. 1997. Neuronal injury in meningitis. In: In defense of the brain, Peterson, P. K., and J. S. Remington eds. Blackwell, Malden, MA, pp. 124–143.Google Scholar
  8. 8.
    Fang, C. T., Y. C. Chen, S. C. Chang, W. Y. Sau, and K. T. Luh. 2000. Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM. 93:45–53.PubMedCrossRefGoogle Scholar
  9. 9.
    Leppert, D., S. L. Leib, C. Grygar, K. M. Miller, U. B. Schaad, and G. A. Holländer. 2000. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood–brain barrier damage and neurological sequelae. Clin. Infect. Dis. 31:80–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Yushchenko, M., F. Weber, M. Mäder, U. Schöll, M. Maliszewska, H. Tumani, K. Felgenhauer, and W. Beuche. 2000. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J. Neuroimmunol. 110:244–251.PubMedCrossRefGoogle Scholar
  11. 11.
    Yong, V. W., C. A. Krekoski, P. A. Forsyth, R. Bell, and D. R. Edwards. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:75–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Gottschall, P. E., and S. Deb. 1996. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation. 3:69–75.PubMedCrossRefGoogle Scholar
  13. 13.
    Apodaca, G., J. T. Rutka, K. Bouhana, M. E. Berens, J. R. Giblin, M. L. Rosenblum, J. H. McKerrow, and M. J. Banda. 1990. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res. 50:2322–2329.PubMedGoogle Scholar
  14. 14.
    Uhm, J. H., N. P. Dooley, L. Y. Oh, and V. W. Yong. 1998. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia. 22:53–63.PubMedCrossRefGoogle Scholar
  15. 15.
    Leib, S. L., J. M. Clements, R. L. Lindberg, C. Heimgartner, J. M. Loeffler, L. A. Pfister, M. G. Tauber, and D. Leppert. 2001. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 124:1734–1742.PubMedCrossRefGoogle Scholar
  16. 16.
    Leib, S. L., Y. S. Kim, L. L. Chow, R. A. Sheldon, and M. G. Tauber. 1996. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Invest. 98:2632–2639.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee, H. C., Y. C. Chuang, W. L. Yu, N. Y. Lee, C. M. Chang, N. Y. Ko, L. R. Wang, and W. C. Ko. 2006. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J. Intern, Med. 259:606–614.CrossRefGoogle Scholar
  18. 18.
    Nadasy, K. A., R. Domiati-Saad, and M. A. Tribble. 2007. Invasive Klebsiella pneumoniae syndrome in North America. Clin. Infect. Dis. 45:25–28.CrossRefGoogle Scholar
  19. 19.
    Fang, C. T., Y. P. Chuang, C. T. Shun, S. C. Chang, and J. T. Wang. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 199:697–705.PubMedCrossRefGoogle Scholar
  20. 20.
    Nassif, X., N. Honore, T. Vasselon, S. T. Cole, and P. J. Sansonetti. 1989. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae. Mol. Microbiol. 3:1349–1359.PubMedCrossRefGoogle Scholar
  21. 21.
    Kolb, S. A., F. Lahrtz, R. Paul, D. Leppert, D. Nadal, H. W. Pfister, and A. Fontana. 1998. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: up-regulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84:143–150.PubMedCrossRefGoogle Scholar
  22. 22.
    Rosenberg, G. A., E. Y. Estrada, J. E. Dencoff, and W. G. Stetler-Stevenson. 1995. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood–brain barrier: an expanded therapeutic window. Brain Res. 703:151–155.PubMedCrossRefGoogle Scholar
  23. 23.
    Yu, W. L., W. C. Ko, K. C. Cheng, H. C. Lee, D. S. Ke, C. C. Lee, C. P. Fung, and Y. C. Chuang. 2006. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis. 42:1351–1358.PubMedCrossRefGoogle Scholar
  24. 24.
    Ma, L. C., C. T. Fang, C. Z. Lee, C. T. Shun, and J. T. Wang. 2005. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J. Infect. Dis. 192:117–128.PubMedCrossRefGoogle Scholar
  25. 25.
    Miller, A., S. Shapiro, N. Lahat, and Y. Galboiz. 2002. Matrix metalloproteinases and their inhibitors in brain injury and repair. In: Brain disease: therapeutic strategies and repair, Abramsky, O., D. A. S. Comspton, A. Miller, and G. Said eds. Martin Dunitz, UK, pp. 63–68.Google Scholar
  26. 26.
    Keiseier, B. C., T. Seifert, G. Giovannoni, and H. P. Hartung. 1999. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology. 53:20–25.CrossRefGoogle Scholar
  27. 27.
    Harkness, K. A., P. Adamson, J. D. Sussman, G. A. Davies-Jones, J. Greenwood, and M. N. Woodroofe. 2000. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain. 123:698–709.PubMedCrossRefGoogle Scholar
  28. 28.
    Rosenberg, G. A., J. E. Dencoff, N. Correa Jr, M. Reiners, and C. C. Ford. 1996. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood–brain barrier injury. Neurology. 46:1626–1632.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Hung-Chin Tsai
    • 1
    • 2
    • 3
  • Sheng-Fu Liu
    • 4
  • Kuan-Sheng Wu
    • 1
    • 2
  • Yung-Ching Liu
    • 1
    • 2
  • Min-Hon Shi
    • 1
    • 2
  • Eng-Rin Chen
    • 3
  • Chuan-Min Yen
    • 3
  • Susan Shin-Jung Lee
    • 1
    • 2
  • Yen-Lin Huang
    • 1
    • 2
  • Yao-Shen Chen
    • 1
    • 2
    • 5
  1. 1.Section of Infectious Diseases, Department of MedicineKaohsiung Veterans General HospitalKaohsiungTaiwan
  2. 2.National Yang-Ming UniversityTaipeiRepublic of China
  3. 3.Graduate Institute of MedicineKaohsiung Medical UniversityKaohsiungTaiwan
  4. 4.College of MedicineKaohsiung Medical UniversityKaohsiungTaiwan
  5. 5.Institute of Environmental EducationNational Kaohsiung Normal UniversityKaohsiungTaiwan

Personalised recommendations